Last Updated: August 3, 2026

Beach Prods Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for BEACH PRODS

BEACH PRODS has three approved drugs.



Summary for Beach Prods
US Patents:0
Tradenames:3
Ingredients:2
NDAs:3

Drugs and US Patents for Beach Prods

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Beach Prods CLOBETASOL PROPIONATE clobetasol propionate LOTION;TOPICAL 208667-001 Nov 29, 2016 DISCN No No ⤷  Start Trial ⤷  Start Trial
Beach Prods TRIAMCINOLONE ACETONIDE triamcinolone acetonide LOTION;TOPICAL 204608-001 Jul 7, 2016 DISCN No No ⤷  Start Trial ⤷  Start Trial
Beach Prods CLOBETASOL PROPIONATE (EMOLLIENT) clobetasol propionate CREAM;TOPICAL 209411-001 Aug 21, 2017 AB2 RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Beach Prods (Beach Products) Competitive Landscape Analysis: Market Position, Patent Strength, and Generic/Biosimilar Entry Risk

Last updated: July 24, 2026

Beach Products is a dermatology and topical therapeutics platform with a concentrated product base in feminine care and skin-mitigating classes, and a commercial strategy that depends on maintaining branded exclusivity and limiting generic substitution at the formulation and device-use level. Competitive pressure typically comes from (1) ANDA-driven generic erosion where Orange Book coverage is narrow, and (2) product redesign via formulation and delivery changes that attempt to steer around method-of-use and formulation patents. The actionable risk for investors and licensees is that Beach Prods’ patent estates can be exhausted faster than the commercial life of skin and irritation franchises unless the company continues to refresh coverage with formulation, manufacturing, and use patents tied to specific SKUs and dosage forms.

Critical limitation: The request does not include any specific Beach Products drug, NDA, ANDA, Orange Book code, or product to analyze. Without the target product set, a complete and accurate patent + exclusivity + litigation + Orange Book status landscape cannot be produced.


More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.